Search

Search Constraints

You searched for: Author/Creator Larrauri, Amparo

Search Results

1. 2015/16 I‐MOVE/I‐MOVE+ multicentre case‐control study in Europe: Moderate vaccine effectiveness estimates against influenza A(H1N1)pdm09 and low estimates against lineage‐mismatched influenza B among children. Issue 4 (14th March 2018)

2. All‐cause versus cause‐specific excess deaths for estimating influenza‐associated mortality in Denmark, Spain, and the United States. Issue 4 (23rd February 2022)

3. Concentrations of nitrogen compounds are related to severe rhinovirus infection in infants. A time‐series analysis from the reference area of a pediatric university hospital in Barcelona. Issue 9 (13th June 2022)

4. COVID‐19 vaccine effectiveness against hospitalization due to SARS‐CoV‐2: A test‐negative design study based on Severe Acute Respiratory Infection (SARI) sentinel surveillance in Spain. Issue 6 (26th July 2022)

5. Defining the seasonality of respiratory syncytial virus around the world: National and subnational surveillance data from 12 countries. Issue 6 (13th July 2021)

6. Determinants of Fatal Outcome in Patients Admitted to Intensive Care Units With Influenza, European Union 2009–2017. (29th October 2019)

7. Effectiveness of a Second Dose of an mRNA Vaccine Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Omicron Infection in Individuals Previously Infected by Other Variants. (11th July 2022)

8. Effectiveness of influenza vaccine against influenza A in Europe in seasons of different A(H1N1)pdm09 and the same A(H3N2) vaccine components (2016–17 and 2017–18). (10th December 2019)

9. Effectiveness of mRNA vaccine boosters against infection with the SARS-CoV-2 omicron (B.1.1.529) variant in Spain: a nationwide cohort study. Issue 9 (September 2022)

10. Erratum to "Predominance of influenza A(H3N2) virus genetic subclade 3C.2a1 during an early 2016/17 influenza season in Europe – Contribution of surveillance data from World Health Organization (WHO) European region to the WHO vaccine composition consultation for northern hemisphere 2017/18" [Vaccine 35 (2017) 4828–4835]. Issue 19 (3rd May 2018)